Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18764578 | 0.92 | CASP3 (0.49) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL30758116 | 0.92 | PTPN1 (0.45) | MDM4TP53CASP3PTPN1 | |
| SCHEMBL30758115 | 0.91 | PTPN1 (0.45) | MDM4TP53PTPN1 | |
| SCHEMBL20545940 | 0.89 | MDM4 (0.45) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL30529863 | 0.88 | CASP3 (0.42) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL29812620 | 0.87 | MDM4 (0.44) | MDM4TP53CASP3KMT2A | |
| SCHEMBL18790463 | 0.87 | CASP3 (0.49) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL29519883 | 0.86 | CASP3 (0.50) | MDM4TP53CASP3KMT2A | |
| SCHEMBL2193899 | 0.86 | CASP3 (0.43) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL2193892 | 0.86 | CASP3 (0.43) | MDM4TP53CASP3KMT2APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023231969-A1 | INSULIN HYBRID PEPTIDE COMPRISING CHYMOTRYPSIN INHIBITORY PEPTIDE, AND USE THEREOF | 中国医学科学院药物研究所 | 2023-12-07 | — | — | WO | disclosed |
| WO-2022111713-A1 | POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF | 中国医学科学院药物研究所 | 2022-06-02 | — | — | WO | disclosed |